Found 15 matching trials
IFM 2005-01: Velcade/Dexamethasone Versus Vincristine/Adriamycin (Doxorubicin)/Dexamethasone (VAD) for the Treatment of Patients With Multiple Myeloma PHASE3 This is an open-label, multi-centre, randomised Phase III study, looking at...
Show More Location
CHU de Nantes, Service d'Hématologie
Learn More & Join Trial
Treatment of Mantle Cell Lymphoma at Diagnosis for Patients Under 65 Years PHASE2 Phase II study to test in first line the VAD (Vincristine Adriablastine Dex...
Show More Location
Regional university hospital
Learn More & Join Trial
Velcade (Bortezomib), Adriamycin Dexamethasone (PAD) or Vincristine Adriamycin Dexamethasone in Second Line Treatment of Multiple Myeloma PHASE2 The purpose of this research study is to test the safety and effectiveness ...
Show More Location
Multiple Locations
Learn More & Join Trial
Combination Chemotherapy With or Without PSC 833 in Treating Patients With Relapsed or Refractory Multiple Myeloma PHASE3 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Show More Location
University of California San Diego Cancer Center
Learn More & Join Trial
Multiple Myeloma Treated With Thalidomide Before Autotransplant or With Conventional Chemotherapy and as Consolidation/Maintenance Treatment in Young and Elderly Patients : 3 Randomized Studies. PHASE3 The aim of the study was to evaluate efficacy and tolerability of Thalidomi...
Show More Location
CHU CAEN Dept of Hematology
Learn More & Join Trial
Sequential High-dose Dexamethasone and Response Adopted PAD or VAD Induction Chemotherapy Followed by High-dose Chemotherapy With Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma PHASE2 Complete Response (CR) plus near CR rate of VAD (Vincristine, Adriamycin, D...
Show More Location
National Cancer Center
Learn More & Join Trial
Sequential VAD and VTD Followed by HDT With ASCT and Velcade Maintenance for NDMM PHASE2 1. Primary Objective To assess the response rate of sequential VAD (Vincris...
Show More Location
Seoul National University Hospital
Learn More & Join Trial
Combination Chemotherapy in Treating Patients With Stage II or Stage III Multiple Myeloma PHASE3 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Show More Location
Birmingham Heartlands Hospital
Learn More & Join Trial
Combination Chemotherapy and Thalidomide in Treating Patients With Stage I, Stage II, or Stage III Multiple Myeloma PHASE2 RATIONALE: Drugs used in chemotherapy work in different ways to stop cancer...
Show More Location
Roswell Park Cancer Institute
Learn More & Join Trial
UARK 98-026 TT II: Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation Chemotherapy PHASE3 This study has been designed to evaluate whether "anti-angiogenesis" therap...
Show More Location
University of Arkansas for Medical Sciences/MIRT
Learn More & Join Trial